Recent post-hoc analyses of two Phase 3 clinical trials show that RA patients with high interleukin 6 levels taking sarilumab experienced improved symptoms and less joint damage than those using other treatments…
Patients with Prediabetes May Be Predisposed to Arthritis
New research from the CDC shows that approximately one-third of U.S. adults with prediabetes also have arthritis, which can prevent physical activity in these patients, thereby, making it more likely they will develop type 2 diabetes…
Judge Signals Skepticism in Trump Team’s Bid to Block Obamacare Suit
(Reuters)—A U.S. judge signaled skepticism on Wednesday toward a bid by President Donald Trump’s administration to block a lawsuit by the state of Maryland seeking to preserve the Obamacare law in a case that also challenges Trump’s appointment of Matthew Whitaker as acting attorney general. At a nearly three-hour hearing in federal court in Baltimore,…
Cigna Closes $54 Billion Purchase of Express Scripts
NEW YORK (Reuters)—Cigna Corp on Thursday closed its $54-billion deal to buy Express Scripts Holding Co, creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination and cut costs. Cigna’s deal puts it in direct competition with two other…
Sign-ups for 2019 Obamacare Insurance Fall to 8.5 Million People
NEW YORK (Reuters)–The number of Americans who signed up for 2019 insurance plans created by the Affordable Care Act, often called Obamacare, fell by about 4 percent to 8.5 million people from 2018, the U.S. government said on Wednesday. Enrollment had been running about 10 percent lower but picked up during the past week, reflecting…
Maryland Judge to Weigh Obamacare Case
(Reuters)—Days after a judge in Texas declared that the Obamacare healthcare law is unconstitutional, Maryland’s Democratic attorney general on Wednesday will pursue his request that another judge rule the opposite way. The lawsuit brought by Maryland Attorney General Brian Frosh also seeks to challenge President Donald Trump’s appointment of Matthew Whitaker as acting attorney general,…
Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD
“It is with a profoundly heavy heart that I share with you the sad news that we have lost one of our most beloved leaders at NIH. Steve Katz, MD, PhD, the long-time director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), died early this morning after suffering a catastrophic stroke….
How Advances in Artificial Intelligence May Aid Rheumatology
From digital scribes to predictive pharmacology—as artificial intelligence advances, technology has a lot to offer medicine. What opportunities lie ahead for rheumatologists and their patients?
Bimekizumab Promising for PsA
CHICAGO—Bimekizumab is an investigational interleukin (IL) 17A and IL-17 neutralizing agent being studied to modulate inflammation in psoriasis, psoriatic arthritis and ankylosing spondylitis. During the late-breaking abstract session at the 2018 ACR/ARHP Annual Meeting, researchers reported on the results of a 48-week, Phase 2b, randomized, double-blind, placebo-controlled study of bimekizumab in patients with active psoriatic…
New Guideline for the Treatment of Psoriatic Arthritis
ACR guidelines include recommendations for the management of patients with particular conditions or diseases. Guidelines are developed using a systematic process and are based on available evidence and the clinical experience and expertise of rheumatologists and other interested stakeholders. In the January issue of Arthritis & Rheumatology, Arthritis Care & Research and the Journal of…
- « Previous Page
- 1
- …
- 124
- 125
- 126
- 127
- 128
- …
- 310
- Next Page »